BackWindtree Therapeutics Overview

Windtree Therapeutics Research & Development

Research & Development expenses for WINT.

Quarterly R&D Expenses

$1.90M
↓ 3.61% YoY

As of Sep 30, 2025

Annual R&D Expenses (TTM)

$8.54M
↓ 49.96% YoY

Trailing 12 months ending Sep 30, 2025

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin